Chemoinformaics analysis of TRANS-DIPROPENYL DISULFIDE
| Molecular Weight | 146.28 | nRot | 3 |
| Heavy Atom Molecular Weight | 136.2 | nRig | 2 |
| Exact Molecular Weight | 146.022 | nRing | 0 |
| Solubility: LogS | -2.496 | nHRing | 0 |
| Solubility: LogP | 3.247 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.4879 |
| nHD | 0 | BPOL | 12.4921 |
| QED | 0.442 |
| Synth | 4.687 |
| Natural Product Likeliness | 1.335 |
| NR-PPAR-gamma | 0.669 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.426 |
| MDCK | 0.0000132 |
| BBB | 0.869 |
| PPB | 0.608099 |
| VDSS | 2.256 |
| FU | 0.368452 |
| CYP1A2-inh | 0.984 |
| CYP1A2-sub | 0.44 |
| CYP2c19-inh | 0.929 |
| CYP2c19-sub | 0.657 |
| CYP2c9-inh | 0.467 |
| CYP2c9-sub | 0.848 |
| CYP2d6-inh | 0.663 |
| CYP2d6-sub | 0.645 |
| CYP3a4-inh | 0.195 |
| CYP3a4-sub | 0.199 |
| CL | 12.53 |
| T12 | 0.582 |
| hERG | 0.003 |
| Ames | 0.911 |
| ROA | 0.309 |
| SkinSen | 0.962 |
| Carcinogencity | 0.052 |
| EI | 0.995 |
| Respiratory | 0.984 |
| NR-Aromatase | 0.525 |
| Antiviral | No |
| Prediction | 0.945276 |